Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Bedridden, Disability, Gait disturbance, Hypoaesthesia, Hypokinesia
Clinical narrative: he crippled; not able to move; he has extreme pain/stabbing pain; he has overactive immune system; he can hardly walk; he can not do anything by himself/can not go to bathroom; can not get out of bed; he can not come down to eat so I need to bring food; when he is trying to lie down I need to lift up his feet,; he can barely feels his feet, its numb; This spontaneous case was reported by a consumer and describes the occurrence of DISABILITY (he crippled) and IMMOBILE (not able to move) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Polymyalgia. Concomitant products included PREDNISONE for Polymyalgia.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Apr-2021, the patient experienced DISABILITY (he crippled) (seriousness criterion medically significant), IMMOBILE (not able to move) (seriousness criterion medically significant), PAIN (he has extreme pain/stabbing pain), IMMUNE SYSTEM DISORDER (he has overactive immune system), GAIT DISTURBANCE (he can hardly walk), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (he can not do anything by himself/can not go to bathroom), BEDRIDDEN (can not get out of bed), MOBILITY DECREASED (he can not come down to eat so I need to bring food), HYPOKINESIA (when he is trying to lie down I need to lift up his feet,) and HYPOAESTHESIA (he can barely feels his feet, its numb). At the time of the report, DISABILITY (he crippled), IMMOBILE (not able to move), PAIN (he has extreme pain/stabbing pain), IMMUNE SYSTEM DISORDER (he has overactive immune system), GAIT DISTURBANCE (he can hardly walk), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (he can not do anything by himself/can not go to bathroom), BEDRIDDEN (can not get out of bed), MOBILITY DECREASED (he can not come down to eat so I need to bring food), HYPOKINESIA (when he is trying to lie down I need to lift up his feet,) and HYPOAESTHESIA (he can barely feels his feet, its numb) had not resolved. Not Provided          Additional concomitant medications included blood pressure medication (not otherwise specified).  Treatment information was not provided.  The patient received both scheduled doses of mRNA-1273 prior to the event(s); therefore, action taken with the drug in response to the event(s) is not applicable.  Though the events reported are expected due to the patient's medical history of polymyalgia, based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-114778 (Patient Link).; Sender's Comments: Though the events reported are expected due to the patient's medical history of polymyalgia, based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.